Insider Trading March 25, 2026

Nucor Chair Leon Topalian Sells $1.86M in Stock as Company Issues Q1 Guidance

Topalian completed two paid dispositions totaling $1.86 million; Nucor projects substantially higher Q1 2026 EPS and draws mixed analyst reactions

By Sofia Navarro NUE
Nucor Chair Leon Topalian Sells $1.86M in Stock as Company Issues Q1 Guidance
NUE

Leon J. Topalian, chair and CEO of Nucor Corporation (NUE), sold $1.86 million of company shares on March 23, 2026, across two priced transactions and a separate disposal recorded at zero value. The transactions were disclosed on a Form 4 filing. Nucor is trading near its fair value, has maintained dividend payments for 54 consecutive years, and issued Q1 2026 EPS guidance of $2.70 to $2.80 per share that aligns with analyst expectations.

Key Points

  • Nucor CEO Leon J. Topalian sold a total of $1.86 million in company stock on March 23, 2026, across two priced transactions and a separate disposal recorded at $0.
  • Nucor issued Q1 2026 EPS guidance of $2.70 to $2.80, closely matching analyst expectations of $2.71 and representing a sizable increase from $0.77 in the year-ago quarter.
  • Analyst reactions were mixed-to-positive: BofA reiterated Buy with a $190 target, Morgan Stanley kept an Equalweight rating at $180, and KeyBanc initiated coverage with a Sector Weight and a $5.40 billion 2026 EBITDA estimate.

Leon J. Topalian, chair and chief executive officer of Nucor Corporation (NYSE: NUE), reported insider sales totaling $1.86 million on March 23, 2026, according to a Form 4 filed with the Securities and Exchange Commission.

The disclosure breaks the activity into two priced transactions and one additional disposal. In the first priced sale, Topalian sold 6,454 shares at a weighted average price of $162.0084, producing proceeds of $1,045,606. In the second priced sale, he disposed of 5,046 shares at a weighted average price of $162.4028, yielding $819,480. Separately, the filing records the disposition of 3,800 shares in a transaction reported with a value of $0.

Following these transactions, Topalian's direct holdings in Nucor total 147,641.47 shares. He also retains an indirect interest of 1,361.69 shares through a profit-sharing plan, as shown in the SEC filing.


Market context accompanying the filing highlights that Nucor shares were trading at $165.45 at the time of the report, reflecting a 29.7% total return over the previous 12 months. Analysis from InvestingPro cited in the filing indicates the stock sits near its Fair Value estimate, suggesting it is roughly fairly valued. The firm also notes that Nucor has paid dividends for 54 consecutive years.

In separate corporate disclosures, Nucor issued guidance for the first quarter of 2026, forecasting earnings per share between $2.70 and $2.80. That range is in close alignment with consensus analyst expectations of $2.71 per share and marks a substantial increase from the $0.77 per share the company reported in the same quarter a year earlier.

The company expects earnings to improve across all operating segments. Management projects the steel mills segment will contribute the most to growth, driven by higher selling prices and greater volumes. The steel products segment is anticipated to see improved results as a consequence of increased volumes and stable pricing.

Several brokerages have commented following the guidance. BofA Securities reiterated its Buy rating on Nucor and set a $190 price target, noting that the company's guidance aligns with its estimates. Morgan Stanley maintained an Equalweight rating and a $180 price target, citing expectations that Nucor will outperform peers based on its guidance. KeyBanc initiated coverage with a Sector Weight rating and adjusted its 2026 EBITDA estimate to $5.40 billion, pointing to higher earnings in the steel mills segment.

Collectively, the insider transactions, current market valuation, company guidance and analyst notes present a snapshot of Nucor at a moment of positive forecasted operating performance coincident with an insider sale. The filings and commentary provide investors with factual detail on executive holdings, recent corporate guidance and how several analysts are positioning their ratings and estimates in response.

Risks

  • The company's guidance depends on higher selling prices and increased volumes in the steel mills segment - if selling prices or volumes fall short, expected earnings increases may not materialize (impacts: steel sector, industrials).
  • Nucor's stock is trading near its estimated Fair Value, which may indicate limited upside from current levels and could affect investor return prospects (impacts: equity markets, investor portfolios).
  • The insider sale may be interpreted variably by market participants, potentially influencing perceptions of insider confidence in the short term (impacts: market sentiment, equities).

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026